NY A 3963
in committeeIncludes Suvorexant in the Schedule IV list of depressant drugs
New York · 2025-2026 Regular Session · lower
Quick answers
Did NY A 3963 pass?
Not yet. NY A 3963 is in committee as of 2026-01-07 and has not come to a final vote. Latest recorded action (2026-01-07): REFERRED TO HEALTH
What is NY A 3963 about?
Includes sleep medication Suvorexant in the Schedule IV list of depressant drugs.
Who sponsors NY A 3963?
John T. McDonald III is the primary sponsor of NY A 3963.
Description
Includes sleep medication Suvorexant in the Schedule IV list of depressant drugs.
- Introduced
- —
- Latest action
- 2026-01-07 — REFERRED TO HEALTH
- Bill type
- bill
- Last updated
- —
Sponsors
- John T. McDonald IIIprimary
Committees
Not provided by source.
Action timeline
2025-01-30
REFERRED TO HEALTH
referral-committee
2026-01-07
REFERRED TO HEALTH
referral-committee
Versions
- A3963Compare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=A 3963. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.